Swiss Life Asset Management’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $333M | Sell |
769,346
-17,926
| -2% | -$5.44M | 1.38% | 11 |
|
|
2026
Q1 | $168M | Buy |
787,272
+35,706
| +5% | +$7.98M | 0.82% | 17 |
|
|
2025
Q4 | $129M | Buy |
751,566
+210,753
| +39% | +$32.8M | 0.66% | 23 |
|
|
2025
Q3 | $72.4M | Buy |
540,813
+8,483
| +2% | +$898K | 0.38% | 51 |
|
|
2025
Q2 | $51.8M | Buy |
532,330
+125,875
| +31% | +$9.98M | 0.31% | 67 |
|
|
2025
Q1 | $29.5M | Buy |
406,455
+7,303
| +2% | +$575K | 0.21% | 89 |
|
|
2024
Q4 | $28.8M | Buy |
399,152
+60,272
| +18% | +$4.57M | 0.21% | 85 |
|
|
2024
Q3 | $27.6M | Sell |
338,880
-250
| -0.1% | -$21.7K | 0.31% | 70 |
|
|
2024
Q2 | $36.1M | Buy |
339,130
+21,690
| +7% | +$2.08M | 0.43% | 50 |
|
|
2024
Q1 | $30.8M | Sell |
317,440
-78,010
| -20% | -$6.86M | 0.43% | 57 |
|
|
2023
Q4 | $31M | Buy |
395,450
+33,560
| +9% | +$2.29M | 0.37% | 48 |
|
|
2023
Q3 | $22.7M | Sell |
361,890
-41,760
| -10% | -$2.74M | 0.35% | 54 |
|
|
2023
Q2 | $26M | Sell |
403,650
-11,440
| -3% | -$645K | 0.38% | 43 |
|
|
2023
Q1 | $22M | Buy |
415,090
+63,430
| +18% | +$3.11M | 0.33% | 60 |
|
|
2022
Q4 | $14.8M | Buy |
351,660
+20,850
| +6% | +$872K | 0.25% | 98 |
|
|
2022
Q3 | $12.1M | Sell |
330,810
-4,500
| -1% | -$200K | 0.21% | 122 |
|
|
2022
Q2 | $14.3M | Buy |
335,310
+136,090
| +68% | +$6.48M | 0.23% | 95 |
|
|
2022
Q1 | $10.7M | Buy |
199,220
+1,870
| +0.9% | +$109K | 0.15% | 153 |
|
|
2021
Q4 | $14.2M | Sell |
197,350
-49,990
| -20% | -$3.13M | 0.18% | 123 |
|
|
2021
Q3 | $14.1M | Sell |
247,340
-38,810
| -14% | -$2.36M | 0.2% | 117 |
|
|
2021
Q2 | $15.2M | Sell |
286,150
-53,900
| -16% | -$3.4M | 0.15% | 123 |
|
|
2021
Q1 | $20.2M | Buy |
340,050
+3,090
| +0.9% | +$168K | 0.29% | 75 |
|
|
2020
Q4 | $15.9M | Sell |
336,960
-640,860
| -66% | -$27M | 0.23% | 94 |
|
|
2020
Q3 | $32.4M | Buy |
977,820
+29,230
| +3% | +$1.01M | 0.48% | 42 |
|
|
2020
Q2 | $30.7M | Sell |
948,590
-950
| -0.1% | -$25.9K | 0.49% | 41 |
|
|
2020
Q1 | $22.8M | Buy |
949,540
+807,680
| +569% | +$23.3M | 0.43% | 50 |
|
|
2019
Q4 | $4.15M | Buy |
141,860
+510
| +0.4% | +$13.5K | 0.08% | 199 |
|
|
2019
Q3 | $3.27M | Sell |
141,350
-18,760
| -12% | -$394K | 0.04% | 237 |
|
|
2019
Q2 | $3M | Buy |
160,110
+127,650
| +393% | +$2.42M | 0.04% | 244 |
|
|
2019
Q1 | $581K | Buy |
+32,460
| New | +$542K | 0.01% | 407 |
|
|
2018
Q4 | – | Sell |
-70,010
| Closed | -$1.06M | – | 349 |
|
|
2018
Q3 | $1.06M | Sell |
70,010
-107,490
| -61% | -$1.84M | 0.01% | 391 |
|
|
2018
Q2 | $3.07M | Sell |
177,500
-15,800
| -8% | -$304K | 0.05% | 225 |
|
|
2018
Q1 | $3.93M | Buy |
193,300
+141,410
| +273% | +$2.8M | 0.07% | 212 |
|
|
2017
Q4 | $956K | Sell |
51,890
-79,660
| -61% | -$1.57M | 0.02% | 353 |
|
|
2017
Q3 | $2.43M | Sell |
131,550
-16,560
| -11% | -$269K | 0.07% | 180 |
|
|
2017
Q2 | $2.09M | Sell |
148,110
-93,680
| -39% | -$1.37M | 0.05% | 184 |
|
|
2017
Q1 | $3.1M | Sell |
241,790
-50,600
| -17% | -$595K | 0.08% | 138 |
|
|
2016
Q4 | $3.09M | Sell |
292,390
-12,940
| -4% | -$131K | 0.1% | 127 |
|
|
2016
Q3 | $2.89M | Buy |
+305,330
| New | +$2.78M | 0.1% | 126 |
|
|
2016
Q2 | – | Sell |
-186,560
| Closed | -$1.54M | – | 354 |
|
|
2016
Q1 | $1.54M | Buy |
+186,560
| New | +$1.36M | 0.07% | 150 |
|
|
2015
Q3 | – | Sell |
-78,500
| Closed | -$639K | – | 329 |
|
|
2015
Q2 | $639K | Buy |
78,500
+31,370
| +67% | +$246K | 0.02% | 172 |
|
|
2015
Q1 | $331K | Buy |
+47,130
| New | +$373K | 0.01% | 206 |
|
Other funds holding LRCX
N
Swiss Life Asset Management's LRCX Position: Q2 2026 in Review
Swiss Life Asset Management reduced its Lam Research (LRCX) stake by 2.3% in Q2 2026, selling an estimated $5.44M and leaving 769,346 shares worth $333M. The position accounts for 1.38% of the portfolio, ranked #11.
Swiss Life Asset Management first reported a position in LRCX in Q1 2015 and has held it in 42 quarters since. 2,305 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Swiss Life Asset Management held 769,346 shares of Lam Research worth $333M as of Q2 2026.
- Swiss Life Asset Management sold 17,926 Lam Research shares in Q2 2026, an estimated $5.44M.
- Lam Research made up 1.38% of Swiss Life Asset Management's portfolio in Q2 2026, its #11 holding.
- Swiss Life Asset Management first reported a position in Lam Research in Q1 2015 and has held it in 42 quarters since.
- 2,305 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.